Allan Davies
Australia
Research Article
Polypharmacy is Associated with Co-morbidity and Predicts outcome in Patients undergoing Index Pulmonary Hypertension Assessment
Author(s): Michael McGee, Avedis Ekmejian, Seshika Ratwatte, Allan Davies, Stuart Turner and Nicholas Collins*
Michael McGee, Avedis Ekmejian, Seshika Ratwatte, Allan Davies, Stuart Turner and Nicholas Collins*
Aims: We sought to evaluate the incidence of polypharmacy in patients referred for pulmonary hypertension assessment, assess the relationship of polypharmacy to the presence of co-morbidity and document the influence of polypharmacy and co-morbidity on unplanned readmissions and mortality in this cohort.
Methods: We performed an audit of outpatient clinical medical records for 215 consecutive patients referred to a tertiary referral centre for pulmonary hypertension assessment between March 2009 and April 2016. Data on number and class of medications were recorded, as well as past medical history and investigations relevant to assessment of pulmonary hypertension.
Results: At the time of pulmonary hypertension evaluation, patients were prescribed a mean of 8 ± 4 medications with 83.2% of patients being on 5 .. View More»
DOI:
10.4172/2329-6607.1000242